Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
DexCom (DXCM) PT Lowered to $553 at Cowen
February 11, 2022 7:26 AM ESTCowen analyst Joshua Jennings lowered the price target on DexCom (NASDAQ: DXCM) to $553.00 (from $655.00) while maintaining an Outperform rating.
The analyst commented, "After releasing its 4Q21 sales results and 2022 revenue guidance last month, DXCM today reported its full 4Q21 results and provided its 2022... More
DexCom (DXCM) Misses Q4 EPS by 17c
February 10, 2022 4:05 PM ESTDexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96... More
